APX-002 (Apexigen/Jiangsu T-mab BioPharma)
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameAPX-002 (Apexigen/Jiangsu T-mab BioPharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEpitomics IncJiangsu T-Mab Bio-Pharmaceuticals Co LtdApexigen Inc
China Registration ClassN/A
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A